Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
March 18, 2024 - Page 2 of 4 - The Dermatology Digest
Search

Power of Two: Perspective, BMS Partner to Study VMT01 Plus Nivolumab in MC1R-Positive Metastatic Melanoma

Perspective Therapeutics, Inc. is partnering with Bristol Myers Squibb (BMS) to evaluate [212Pb]VMT01 in combination with nivolumab (Opdivo, BMS) in patients with histologically confirmed melanoma and positive melanocortin 1 receptor (MC1R) imaging scans. VMT01 is a proprietary clinical-stage low molecular weight peptide that is targeted to the melanocortin subtype 1 receptor (MC1R) which is over-expressed […]